Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
In Vivo Sensitized and In Vitro Activated B Cells Mediate Tumor Regression in Cancer Adoptive Immunotherapy
Journal of Immunology, 08/26/09
Li Q et al. – The data indicate that in vivo primed and in vitro activated B cells can be employed as effector cells for cancer therapy. The synergistic antitumor efficacy of cotransferred activated B effector cells and T effector cells represents a novel approach for cancer adoptive immunotherapy.
Related Articles
The Cellular Bioeffects of Low Intensity Ultrasound
Ultrasound, 11/30/09
Relevance Score: 45%
Cellular Prion Protein Mediates the Toxicity of beta-Amyloid Oligomers: Implications for Alzheimer Disease
Archives of Neurology, 11/19/09
Relevance Score: 44%
The Myxoma Virus M-T5 Ankyrin Repeat Host Range Protein Is a Novel Adaptor That Coordinately Links the Cellular Signaling Pathways Mediated by Akt and Skp1 in Virus-Infected Cells
Journal of Virology, 11/13/09
Relevance Score: 43%
Glycosylation Regulates Prestin Cellular Activity
Journal of the Association for Research in Otolaryngology, 11/11/09
Relevance Score: 43%
Childhood Abuse may Speed up Aging
Ivanhoe, 11/25/09
Relevance Score: 42%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Interleukin 27: a double-edged sword for offense and defense
Journal of Leukocyte Biology, 12/15/09
The sympathetic nervous system modulates CD4+FoxP3+ regulatory T cells via a TGF-[beta]-dependent mechanism
Journal of Leukocyte Biology, 12/15/09
CpG-enhanced CD8+ T-cell responses to peptide immunization are severely inhibited by B cells
European Journal of Immunology, 12/15/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009—10 influenza season: a multicentre, randomised controlled trial
The Lancet - Early Online Publication, 12/15/09
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
The Lancet - Early Online Publication, 12/15/09
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial
The Lancet - Early Online Publication, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


